Scroll Top
Sponsor

Leadership

PDHC Leadership Team

Our Inaugural PDHC Leadership Team includes deep multidisciplinary scientific and business know-how as well as passion for the the discovery and development of future peptide medicines! Collectively, our team represents the cross-section of pharma, biotech, investors, academia, contract R&D organizations and service providers!

Fernando00
Fernando Albericio, Ph.D.

Synthesis Innovation

Initiative Lead

Raheleh00
Raheleh Rezaei Araghi, Ph.D.
Board of Directors, Director

De Novo Design &

Synthesis Innovation

Initiatives Lead

Florence00
Florence Brunel, Ph.D.

Translation into the Clinic

Initiative Lead

Michele Cleary
Michele Cleary, Ph.D.
Board of Directors, Director

Translation into the Clinic

Initiative Lead

Rami00
Rami Hannoush, Ph.D.
Wendy00
Wendy Hartsock, Ph.D.
Board of Directors, Member-at-Large

Co-Founder, PDHC

Synthesis Innovation &

Translation into the Clinic

Initiatives Lead

Antoine00
Antoine Henninot, Ph.D.

Translation into the Clinic

Initiative Lead

Charles00
Charles Johannes, Ph.D.
Board of Directors, Vice President

Co-Founder, PDHC

De Novo Design &

Synthesis Innovation &

Translation into the Clinic

Initiatives Lead

Katerina Leftheris
Katerina Leftheris, Ph.D.

De Novo Design

Initiative Lead

Danielle Molinari
Danielle Molinari
Board of Directors, Clerk

Project & Operations Manager, PDHC

Anthony Partridge
Anthony Partridge, Ph.D.
Board of Directors, Director

De Novo Design &

Translation into the Clinic

Initiatives Lead

 

Jonathon00
Jonathon Sawyer, Ph.D.
Board of Directors, Treasurer

De Novo Design &

Synthesis Innovation &

Translation into the Clinic

Initiatives Lead

Thomas Sawyer
Thomas Sawyer, Ph.D.

Editor, PDHC Chronicle

Tomi Sawyer
Tomi Sawyer, Ph.D.
Board of Directors, President

Founder, PDHC

Christina00
Christina Schroeder, Ph.D.
Board of Directors, Director
Ved
Ved Srivastava, Ph.D.
Board of Directors, Member-at-Large

De Novo Design

Initiative Lead